Holodiag (HoloDiag)
Premium PartnerIs this your company? Claim this profile
Analytical & Bioanalytical Services
Company Overview
About
Holodiag (HoloDiag) is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:France
Founded:2013
Employees:1,902
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Global
Manufacturing Facilities
1 site worldwide
Holodiag
Pharmaparc II Voie de l'Innovation, Val de Reuil, Normandie, 27100
Site Capabilities
1 capabilityANALYSIS
Regulatory Approvals
Drug Approval SL1NVA
EMA · #APR-JH2N0UWS · 2022-10-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-357NYXBR
Issued: 2020-08-06
Expires: 2025-08-25
ISO 9001:2015
International Organization for Standardization
Cert #: CERT-AGKDAEM4
Issued: 2020-11-28
Expires: 2025-12-07
WHO GMP
World Health Organization
Cert #: CERT-X8UWE21X
Issued: 2020-06-12
Expires: 2025-10-27
Health Canada GMP
Health Canada
Cert #: CERT-IB68EEX4
Issued: 2020-06-11
Expires: 2025-09-07
Loading CDMO intelligence...
Key facts about Holodiag (HoloDiag)
- Holodiag (HoloDiag) is headquartered in France.
- Holodiag (HoloDiag) was founded in 2013.
- Holodiag (HoloDiag) has 1,902 employees.
- Holodiag (HoloDiag) has one manufacturing site listed on CDMO Hub, in Val de Reuil, France.
- Holodiag (HoloDiag)'s capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Holodiag (HoloDiag)
Directory pages this company appears in, each with the full list of matching manufacturers.